We are looking for individuals with Diabetic Macular Edema (DME), between 18 and 75 years old, who have never had treatment for DME or have had some treatment for DME with a type of drug called an “anti-VEGF” medicine to take part in new clinical trial in United States. The aim of this clinical trial is to gain better understanding of the investigational drug, as a possible treatment for individuals with DME.
Les fiers membres et tenants de:
